Clincosm LogoSign in Get a demo

Non-Hodgkins Lymphoma

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and

Recruiting
  • Lymphomatoid Granulomatosis
  • +3 more
  • Interferon
  • Rituxan and EPOCH
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
Has Results
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (JBH492)

Recruiting
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +10 more
Nov 11, 2022

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Huntsville, Bethesda (Ublituximab,

Terminated
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +1 more
May 5, 2022

Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)

Completed
Has Results
  • Non-Hodgkins Lymphoma
  • Fort Myers, Florida
  • +1 more
Feb 21, 2022

Leukemia, Lymphoma, Blood Cancer Trial in Baltimore (Bone Marrow Transplant (BMT))

Recruiting
  • Leukemia
  • +5 more
  • Bone Marrow Transplant (BMT)
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022

Non-Hodgkins Lymphoma Trial in Philadelphia, Houston (hLL2 (epratuzumab))

Terminated
  • Non-Hodgkins Lymphoma
  • hLL2 (epratuzumab)
  • Philadelphia, Pennsylvania
  • +1 more
Aug 12, 2021

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell

Active, not recruiting
  • Leukemia
  • +9 more
  • Fludarabine monophosphate
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 2, 2020

Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)

Completed
  • Non-Hodgkins Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora kinase inhibitor AT9283
  • Vancouver, British Columbia, Canada
  • +1 more
Apr 6, 2020

Prostate Cancer, Non-Hodgkins Lymphoma Trial in Los Angeles, San Antonio, Sutton (SGI-1776)

Terminated
  • Prostate Cancer
  • Non-Hodgkins Lymphoma
  • Los Angeles, California
  • +2 more
Jan 13, 2020

Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma Trial run by the NCI (EPOCH-F/R, FLAG, Transplant Preparative Regimen

Terminated
  • Leukemia
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Non-Hodgkins Lymphoma Trial in United States (Velcade, Temsirolimus)

Completed
Has Results
  • Non-Hodgkins Lymphoma
  • Rapid City, South Dakota
  • +17 more
Dec 11, 2019

Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

Completed
  • Cancer
  • +7 more
  • Scottsdale, Arizona
  • +9 more
Nov 27, 2019

Non-Hodgkins Lymphoma, B-cell Lymphoma, Waldenstrom's Macroglobulinemia Trial in United States (Ublituximab)

Completed
  • Non-Hodgkins Lymphoma
  • +6 more
  • Huntsville, Alabama
  • +7 more
Oct 1, 2019

Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug, biological, procedure, other)

Terminated
Has Results
  • Acute Leukemia
  • +3 more
  • total-body irradiation (TBI)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2018

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • +4 more
  • Allogeneic stem cell transplant
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2018

Non-hodgkins Lymphoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
  • Non-hodgkins Lymphoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Feb 1, 2018

Non-hodgkins Lymphoma Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Terminated
  • Non-hodgkins Lymphoma
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Feb 1, 2018

Non-Hodgkins Lymphoma Trial (CHOP/Rituximab, PEG INTRON)

Completed
  • Non-Hodgkins Lymphoma
  • (no location specified)
Jan 22, 2018

Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Lymphoproliferative Disorder Trial in Washington, Valhalla (EBV CTL's, Peripheral

Completed
  • Non-Hodgkins Lymphoma
  • +2 more
  • EBV CTL's
  • Peripheral Blood Donor
  • Washington, District of Columbia
  • +1 more
Dec 20, 2017

Solid Tumors, Multiple Myeloma, Non-Hodgkins Lymphoma Trial in United States (DCR-MYC)

Terminated
  • Solid Tumors
  • +5 more
  • Stanford, California
  • +5 more
Dec 13, 2017

Non-hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma Trial in Hershey (Oncaspar, Doxil, Decadron)

Terminated
Has Results
  • Non-hodgkins Lymphoma
  • +2 more
  • Oncaspar, Doxil, Decadron
  • Hershey, Pennsylvania
    Penn State Milton S. Hershey Medical Center
Jun 23, 2017

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (Polatuzumab Vedotin, Rituximab)

Completed
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Stanford, California
  • +15 more
Jun 14, 2017

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome (MDS) Trial in Kansas City (Administration of

Completed
Has Results
  • Acute Myeloid Leukemia
  • +4 more
  • Administration of hyperbaric oxygen
  • Kansas City, Kansas
    University of Kansas Medical Center
May 9, 2017